Literature DB >> 7225867

Evidence of the modulatory role of serotonin in acetylcholine release from striatal interneurons.

E S Vizi, L G Hársing, G Zsilla.   

Abstract

The release of acetylcholine was studied in isolated striatal slices of the rat. The spontaneous and ouabain-stimulated release of acetylcholine was higher in those slices where serotonergic input was somehow impaired: raphe nuclei lesion or p-chlorophenylalanine pretreatment or 5, 7-dihydroxytryptamine pretreatment resulted in a higher release. L-(m-chlorophenyl)-piperazine, a pure serotonin receptor stimulant and D-fenfluramine, a serotonin releaser significantly reduced the release of acetylcholine evoked by ouabain. Serotonin antagonists (cyproheptadine, mianserine and methysergide) prevented the effect of serotonin agonists. When the serotonergic neurons were destroyed either by p-chlorophenylalanine or by 5, 7-dihydroxytryptamine pretreatment D-fenfluramine had no inhibitory action; however, the effect of L-(m-chlorophenyl)-piperazine was not affected. It is suggested that there is a link between serotonergic and cholinergic neurons in the striatum: serotonin released from raphe-striatal neurons is able to inhibit the release of acetylcholine from striatal interneurons.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7225867     DOI: 10.1016/0006-8993(81)90035-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system.

Authors:  H Hodges; P Sowinski; J J Turner; A Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1996-05       Impact factor: 4.530

Review 2.  Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Authors:  Maryka Quik; James T Boyd; Tanuja Bordia; Xiomara Perez
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

3.  The selective 5-HT3 receptor antagonist, WAY100289, enhances spatial memory in rats with ibotenate lesions of the forebrain cholinergic projection system.

Authors:  H Hodges; P Sowinski; J D Sinden; C A Netto; A Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

4.  Effect of tianeptine on the central cholinergic system: involvement of serotonin.

Authors:  R Bertorelli; D Amoroso; P Girotti; S Consolo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

5.  Similar ameliorating effects of benzomorphans and 5-HT2 antagonists on drug-induced impairment of passive avoidance response in mice: comparison with acetylcholinesterase inhibitors.

Authors:  K Matsuno; T Senda; K Matsunaga; S Mita; H Kaneto
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Independent effects of cholinergic and serotonergic lesions on acetylcholine and serotonin release in the neocortex of the rat.

Authors:  A J Dekker; L J Thal
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

7.  Serotonergic modulation of anticholinergic effects on cognition and behavior in elderly humans.

Authors:  J T Little; A Broocks; A Martin; J L Hill; L E Tune; C Mack; M Cantillon; S Molchan; D L Murphy; T Sunderland
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

8.  Brain stem serotonin-synthesizing neurons in Alzheimer's disease: a clinicopathological correlation.

Authors:  G M Halliday; H L McCann; R Pamphlett; W S Brooks; H Creasey; E McCusker; R G Cotton; G A Broe; C G Harper
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  Reduction of long-term potentiation in the dentate gyrus of the rat following selective depletion of monoamines.

Authors:  T V Bliss; G V Goddard; M Riives
Journal:  J Physiol       Date:  1983-01       Impact factor: 5.182

10.  The pharmacology of the neurochemical transmission in the midbrain raphe nuclei of the rat.

Authors:  L G Harsing
Journal:  Curr Neuropharmacol       Date:  2006-10       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.